|
KIAA2026 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.42909999892404E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.25460000000022E-06 |
| Normal-vs-Stage2 |
3.788300E-04 |
| Normal-vs-Stage3 |
4.82859999761942E-08 |
| Normal-vs-Stage4 |
4.99590000035965E-07 |
| Stage1-vs-Stage2 |
9.650200E-01 |
| Stage1-vs-Stage3 |
5.890000E-02 |
| Stage1-vs-Stage4 |
1.310390E-01 |
| Stage2-vs-Stage3 |
2.220600E-01 |
| Stage2-vs-Stage4 |
2.376600E-01 |
| Stage3-vs-Stage4 |
9.656600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.42619999646365E-08 |
| Normal-vs-AfricanAmerican |
1.328070E-02 |
| Normal-vs-Asian |
4.649900E-04 |
| Caucasian-vs-AfricanAmerican |
3.566800E-01 |
| Caucasian-vs-Asian |
4.441200E-01 |
| AfricanAmerican-vs-Asian |
7.609400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.08649999686872E-09 |
| Normal-vs-Female |
3.52509999967943E-07 |
| Male-vs-Female |
1.369760E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.54040000000166E-05 |
| Normal-vs-Age(41-60Yrs) |
5.6219999988727E-08 |
| Normal-vs-Age(61-80Yrs) |
1.57769999953317E-07 |
| Normal-vs-Age(81-100Yrs) |
5.809400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.338220E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.086580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.110100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.190600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.101800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.545200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.644420E-01 |
| Classical-VS-Follicular |
4.017800E-01 |
| Classical-VS-Other |
3.612600E-01 |
| Classical-VS-Normal |
1.31140000003693E-06 |
| Tall-VS-Follicular |
4.064200E-01 |
| Tall-VS-Other |
8.187400E-01 |
| Tall-VS-Normal |
3.95099999994653E-06 |
| Follicular-VS-Other |
5.784400E-01 |
| Follicular-VS-Normal |
2.47679999999528E-05 |
| Other-VS-Normal |
1.141820E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.10070000003404E-07 |
| Normal-vs-N1 |
2.35429999999592E-05 |
| N0-vs-N1 |
9.699000E-01 |
|
|
